FACCIOTTI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 7.372
EU - Europa 6.715
AS - Asia 5.560
SA - Sud America 853
Continente sconosciuto - Info sul continente non disponibili 414
AF - Africa 106
OC - Oceania 18
Totale 21.038
Nazione #
US - Stati Uniti d'America 6.938
IT - Italia 2.234
SE - Svezia 2.178
SG - Singapore 1.800
CN - Cina 987
VN - Vietnam 934
HK - Hong Kong 760
BR - Brasile 612
RU - Federazione Russa 551
DE - Germania 528
CA - Canada 296
BD - Bangladesh 247
IE - Irlanda 244
FR - Francia 239
FI - Finlandia 182
IN - India 175
GB - Regno Unito 148
ID - Indonesia 146
KR - Corea 90
ES - Italia 75
AR - Argentina 72
NL - Olanda 66
IQ - Iraq 64
CO - Colombia 56
TR - Turchia 53
AT - Austria 44
CH - Svizzera 44
EC - Ecuador 44
MX - Messico 43
UA - Ucraina 41
PK - Pakistan 40
SA - Arabia Saudita 37
ZA - Sudafrica 36
JP - Giappone 34
PL - Polonia 34
PH - Filippine 33
MY - Malesia 25
VE - Venezuela 23
UZ - Uzbekistan 20
BE - Belgio 17
EG - Egitto 16
JM - Giamaica 16
LT - Lituania 15
TN - Tunisia 15
AU - Australia 14
CR - Costa Rica 14
PY - Paraguay 14
AZ - Azerbaigian 13
CL - Cile 13
HN - Honduras 12
TH - Thailandia 12
AL - Albania 11
IL - Israele 11
MA - Marocco 11
PT - Portogallo 11
CZ - Repubblica Ceca 10
KE - Kenya 10
NI - Nicaragua 10
GE - Georgia 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
PA - Panama 8
TT - Trinidad e Tobago 8
KZ - Kazakistan 7
NP - Nepal 7
PR - Porto Rico 7
DZ - Algeria 6
KG - Kirghizistan 6
RS - Serbia 6
SV - El Salvador 6
BO - Bolivia 5
GR - Grecia 5
PE - Perù 5
UY - Uruguay 5
BG - Bulgaria 4
BH - Bahrain 4
HU - Ungheria 4
IR - Iran 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
RO - Romania 4
TW - Taiwan 4
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
HR - Croazia 3
KH - Cambogia 3
LB - Libano 3
MO - Macao, regione amministrativa speciale della Cina 3
AO - Angola 2
BB - Barbados 2
BZ - Belize 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GY - Guiana 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 20.599
Città #
Stockholm 1.876
Singapore 1.146
Ashburn 832
San Jose 813
Milan 809
Hong Kong 736
Frankfurt am Main 374
Ho Chi Minh City 290
Santa Clara 269
Hanoi 252
Council Bluffs 242
Dublin 228
New York 216
Toronto 187
Chicago 180
Chandler 176
Los Angeles 171
Hefei 160
Dallas 154
Rome 149
Beijing 131
Helsinki 115
Jakarta 115
Princeton 102
Ann Arbor 100
The Dalles 94
Lauterbourg 80
Seoul 78
Buffalo 77
Fairfield 76
Shanghai 73
Columbus 69
Phoenix 62
São Paulo 59
Altamura 56
Boardman 56
Seattle 54
Lawrence 53
Woodbridge 48
Naples 44
Moscow 43
Munich 42
Atlanta 41
Houston 41
Turin 40
Wilmington 40
Montreal 39
San Diego 38
London 36
Da Nang 35
Kent 35
Lappeenranta 35
Denver 34
Hyderabad 34
Dhaka 33
Zurich 32
Bari 30
Figino 30
Haiphong 30
Orem 30
Florence 29
Romola 28
Chennai 27
Nuremberg 27
Turku 26
Salt Lake City 25
Bologna 24
San Francisco 24
Tokyo 24
Rio de Janeiro 23
Cambridge 22
Vienna 22
Brooklyn 21
Warsaw 21
Baghdad 20
Philadelphia 20
Ankara 19
Paris 19
Grafing 18
Boston 17
Las Vegas 17
Tampa 17
Charlotte 16
Genoa 16
Ninh Bình 16
Tashkent 16
Washington 16
Brasília 15
Madrid 15
Can Tho 14
Hải Dương 14
Jeddah 14
Johannesburg 14
Kuala Lumpur 14
Medellín 14
Modena 14
Monza 14
Guayaquil 13
Jacksonville 13
Lahore 13
Totale 12.271
Nome #
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial 2.024
Recent developments in managing luminal microbial ecology in patients with inflammatory bowel disease: from evidence to microbiome-based diagnostic and personalized therapy 434
Microbiota-targeted therapies in inflammation resolution 423
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis 420
Reviving Urban Spaces: Microbial Approaches for Sustainable Regeneration 406
The Association between Vitamin D and Gut Microbiota: A Systematic Review of Human Studies 360
Human Health and Urban Microbiome: the Heritage of a Long Evolutionary Alliance 357
Curing inflammatory bowel diseases: breaking the barriers of current therapies– emerging strategies for a definitive treatment 351
Comparative microbial and functional characterization of kombucha from different starter SCOBYs 348
The One Health approach in urban ecosystem rehabilitation: An evidence-based framework for designing sustainable cities 326
The UniBiome project: microbiome-inspired approaches for a sustainable urban regeneration of Universities 326
Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: Results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 320
Automated multimodal fluorescence microscopy for hyperplex spatial-proteomics: Coupling microfluidic-based immunofluorescence to high resolution, high sensitivity, three-dimensional analysis of histological slides 317
Characterization of Zygosaccharomyces bailii KAV1 Isolated from Kombucha: A Promising Yeast for Human Health Modulation 309
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study 303
The UniBiome project: New microbiome-inspired approaches for a sustainable urban regeneration of Universities 287
Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion 284
Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials 277
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice 267
Gut microbiota-derived metabolites in host physiology 266
IL10 secretion endows intestinal human iNKT cells with regulatory functions towards pathogenic T lymphocytes 261
Tumor infiltrating iNKT cells sustain neutrophil pro-tumorigenic functions influencing disease progression in human colorectal cancer 259
Positive modulation of a new reconstructed human gut microbiota by Maitake extract helpfully boosts the intestinal environment in vitro 257
Environmental protective and risk factors in an at-risk population of subsequent Crohn's Disease 257
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses 255
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models 255
Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area 249
Combined tumor-associated microbiome and immune gene expression profiling predict response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer 236
Estrogen-related differences in antitumor immunity and gut microbiome contribute to sexual dimorphism of colorectal cancer 217
Novel Odoribacter splanchnicus Strain and Its Outer Membrane Vesicles Exert Immunoregulatory Effects in vitro 211
Unconventional T Cells’ Role in Cancer: Unlocking Their Hidden Potential to Guide Tumor Immunity and Therapy 208
Immunological variables associated with clinical and endoscopic response to vedolizumab in patients with inflammatory bowel diseases 208
Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice 204
PCGF6 controls murine Tuft cell differentiation via H3K9me2 modification independently of Polycomb repression 203
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 202
License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity 200
VITAMIN D SUPPLEMENTATION MAY IMPROVE COVID-19 PROGNOSIS? EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS 199
An Intestinal Th17 Subset is Associated with Inflammation in Crohn's Disease and Activated by Adherent-invasive Escherichia coli 197
The Autoimmune Gastritis Puzzle: Emerging Cellular Crosstalk and Molecular Pathways Driving Parietal Cell Loss and ECL Cell Hyperplasia 196
Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease 196
Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes 195
AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn’s disease is suppressed by rfaP and ybaT deletion 185
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis 184
Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive Escherichia coli (AIEC) Virulence and Hamper IL-23/Th17 Axis in Ulcerative Colitis, but Not in Crohn's Disease 181
Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs 177
The Assessment of Multidimensional Clinical, Biological and Patient-Reported Outcomes to Evaluate the Efficacy of Add-On Lactobacillus rhamnosus GG Supplementation in Mild Ulcerative Colitis: A Randomized Pilot Trial 176
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 170
Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers 166
Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes 164
Absence of a role for interleukin-13 in inflammatory bowel disease 159
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 158
Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells 157
The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation 156
Implementation of an automated inclusion system for the histological analysis of murine tissue samples: A feasibility study in DSS-induced chronic colitis 156
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: Data of a national study (ESCAPE-IBD) 155
Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis 155
Baricitinib restrains the immune dysregulation in severe COVID-19 154
Human intestinal and circulating invariant natural killer T cells are cytotoxic against colorectal cancer cells via the perforin–granzyme pathway 153
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease 153
Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus 153
A collaborative robotic solution to partly automate SARS-CoV-2 serological tests in small facilities 153
Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cells 150
NOX2-derived reactive oxygen species are crucial for CD29-induced pro-survival signalling in cardiomyocytes 149
Short-term Oral Antibiotics Treatment Promotes Inflammatory Activation of Colonic invariant Natural killer T and Converntional CD4(+) t Cells 149
IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus 147
Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy 144
Autoimmune gastritis: Diagnosis, clinical management and natural history. A position paper by the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 143
Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism 142
Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications 141
Deciphering the state of immune silence in fatal COVID-19 patients 141
Intestinal IFN-gamma-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease 140
Eomesodermin controls a unique differentiation program in human IL-10 and IFN-gamma coproducing regulatory T cells 140
The CD4-centered universe of human T cell subsets 139
Follistatin-like protein 1 sustains colon cancer cell growth and survival 138
Modulation of intestinal immune cell responses by eubiotic or dysbiotic microbiota in inflammatory bowel diseases 138
Tumor infiltrating Regulatory T cells in sporadic and colitis-associated colorectal cancer: the red little riding hood and the wolf 135
“Fecal Microbiota Transplantation Controls Murine Chronic Intestinal Inflammation by Modulating Immune Cell Functions and Gut Microbiota Composition” 134
Fine tuning by human CD1e of lipid-specific immune responses 134
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan 132
The role of interleukin-13 in chronic inflammatory intestinal disorders 131
Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice 131
Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFN gamma Dependent 131
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 130
Using Robotic Systems to Process and Embed Colonic Murine Samples for Histological Analyses 127
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 126
Impaired SLAM-SLAM homotypic interaction between invariant NKT cells and dendritic cells affects differentiation of IL-4/IL-10-secreting NKT2 cells in nonobese diabetic mice 124
A general and stereoselective route to alpha- or beta-galactosphingolipids via a common four-carbon building block 122
Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6+B helper T cells in systemic lupus erythematosus 120
Immunoproteasome Inhibition Positively Impacts the Gut-Muscle Axis in Duchenne Muscular Dystrophy 107
3D Bioprinted Glioblastoma Multiforme Models: How the Extracellular Matrix Glycosignature Influences Drug Response 99
Nasopharyngeal and oral microbiota profiling in SARS-CoV-2 infected pregnant women 99
UniBiome project: Microbiome-inspired approaches for a sustainable urban regeneration of Universities 93
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice 84
Author's reply: “Anti-parietal cell antibodies are more prevalent and clinically relevant in autoimmune endocrine diseases: Comment on the ARIOSO position paper” 75
Microbiome dysbiosis and endometriosis: a systematic scoping review of current literature and knowledge gaps 66
Corrigendum to “iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis” [Mucosal Immunol. 16(3) (2023) 326–340 66
Exploring the Postbiotic Potential of Zygosaccharomyces bailii KAV1 from Kombucha 65
Pro-inflammatory intestinal Th17-cells are tissue-resident, accumulate in the epithelia in Crohn’s disease, and predict unresponsiveness to vedolizumab 48
The intratumor microbiome and cancer immunity: from pathogenesis to therapeutic opportunities through artificial intelligence 47
Preoperative malnutrition is associated with suppressed intratumoral T cell function and distinct tumor-associated microbiota in colorectal cancer: a prospective pilot study 40
Totale 20.902
Categoria #
all - tutte 69.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.807


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022760 0 0 0 23 231 63 52 47 75 34 48 187
2022/20231.344 128 355 140 89 104 208 53 72 91 33 50 21
2023/20241.112 37 33 55 118 130 178 166 27 151 20 32 165
2024/20253.884 129 425 395 177 271 222 251 96 494 479 330 615
2025/202610.429 997 588 540 865 801 359 1.071 610 667 2.608 531 792
2026/20273.408 512 662 1.372 862 0 0 0 0 0 0 0 0
Totale 21.038